| Index | S&P 500 | P/E | - | EPS (ttm) | -0.21 | Insider Own | 0.64% | Shs Outstand | 222.69M | Perf Week | 2.52% |
| Market Cap | 68.40B | Forward P/E | 19.62 | EPS next Y | 15.66 | Insider Trans | -0.19% | Shs Float | 222.58M | Perf Month | 7.97% |
| Enterprise Value | 85.57B | PEG | - | EPS next Q | - | Inst Own | 54.26% | Short Float | 2.28% | Perf Quarter | 4.98% |
| Income | -48.00M | P/S | 5.43 | EPS this Y | 7.46% | Inst Trans | 0.00% | Short Ratio | 4.62 | Perf Half Y | 1.79% |
| Sales | 12.60B | P/B | 4.12 | EPS next Y | 8.29% | ROA | -0.12% | Short Interest | 5.07M | Perf YTD | 24.34% |
| Book/sh | 74.53 | P/C | 69.72 | EPS next 5Y | 4.86% | ROE | -0.32% | 52W High | 314.86 -2.45% | Perf Year | 21.33% |
| Cash/sh | 4.41 | P/FCF | 33.24 | EPS past 3/5Y | - | ROIC | 0.08% | 52W Low | 229.11 34.06% | Perf 3Y | 8.39% |
| Dividend Est. | 7.24 (2.36%) | EV/EBITDA | 19.54 | Sales past 3/5Y | -1.77% 6.33% | Gross Margin | 32.06% | Volatility | 1.57% 1.73% | Perf 5Y | 4.94% |
| Dividend TTM | 7.22 (2.35%) | EV/Sales | 6.79 | EPS Y/Y TTM | -101.22% | Oper. Margin | -4.71% | ATR (14) | 5.31 | Perf 10Y | 132.23% |
| Dividend Ex-Date | Oct 01, 2026 | Quick Ratio | 0.92 | Sales Y/Y TTM | 4.15% | Profit Margin | -0.38% | RSI (14) | 69.80 | Recom | 2.48 |
| Dividend Gr. 3/5Y | 3.29% 5.90% | Current Ratio | 1.08 | EPS Q/Q | 18.96% | SMA20 | 6.54% | Beta | 0.68 | Target Price | 340.27 |
| Payout | -3379.28% | Debt/Eq | 1.06 | Sales Q/Q | 4.57% | SMA50 | 4.60% | Rel Volume | 0.80 | Prev Close | 308.22 |
| Employees | 21,194 | LT Debt/Eq | 1.01 | Earnings | Nov 05 | SMA200 | 6.29% | Avg Volume | 1.05M | Price | 307.15 |
| IPO Date | Mar 17, 1980 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 4.59% 3.32% | Net Debt/EBITDA | 3.92 | Volume | 845,332 | Change | -0.35% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-15-26 | Reiterated | RBC Capital | Outperform | $358 → $346 |
| Oct-12-26 | Initiated | Barclays | Overweight | $295 → $353 |
| Oct-05-26 | Reiterated | UBS | Neutral | $285 → $305 |
| Sep-09-26 | Reiterated | Argus Research | Buy | $265 → $329 |
| Aug-03-26 | Reiterated | Deutsche Bank | Hold | $315 → $320 |
| Aug-03-26 | Reiterated | Morgan Stanley | Equal Weight | $310 → $320 |
| Jul-31-26 | Reiterated | Bernstein | Outperform | $345 → $373 |
| Jul-31-26 | Reiterated | Wells Fargo | Overweight | $325 → $350 |
| Jul-17-26 | Reiterated | RBC Capital | Outperform | $341 → $358 |
| Jul-17-26 | Reiterated | Bernstein | Outperform | $344 → $345 |
Operating globally, Air Products and Chemicals, Inc. (APD) is a prominent supplier of industrial gases, specialized equipment, and associated services. The company's diverse product range includes atmospheric gases such as oxygen, nitrogen, and argon, as well as various process gases like hydrogen, helium, carbon dioxide, carbon monoxide, and syngas. They also provide a selection of specialty gases. APD is involved in the fabrication of crucial machinery for gas production and handling, including air separation units and non-cryogenic generators. These products and services cater to a broad spectrum of industries, including but not limited to refining, chemical processing, gasification, metals production, general manufacturing, food and beverage, electronics, medical imaging, and energy generation. Moreover, the company's capabilities extend to designing and manufacturing advanced systems for air separation, hydrocarbon recovery and purification, the liquefaction of natural gas, and the secure transportation and storage of liquid helium and hydrogen. APD also engages in a strategic partnership with Baker Hughes Company to further innovate hydrogen compression systems. The firm was established in 1940 and is based in Allentown, Pennsylvania.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 9/30/2025 | FY 2024 9/30/2024 | FY 2023 9/30/2023 | FY 2022 9/30/2022 | FY 2021 9/30/2021 | FY 2020 9/30/2020 | FY 2019 9/30/2019 | FY 2018 9/30/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 12,603 | 12,037 | 12,101 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 8,563 | 8,256 | 8,169 | — | — | — | — | — | — | |
| Gross Profit | 4,039 | 3,781 | 3,932 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 894 | 906 | 942 | — | — | — | — | — | — | |
| Research and Development | 91 | 96 | 100 | — | — | — | — | — | — | |
| Other Operating Expense | 3,649 | 3,656 | -1,576 | — | — | — | — | — | — | |
| Operating Income | -592 | -877 | 4,466 | — | — | — | — | — | — | |
| Interest Expense | 222 | 214 | 219 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 732 | 650 | 574 | — | — | — | — | — | — | |
| Net Income Before Taxes | -82 | -441 | 4,821 | — | — | — | — | — | — | |
| Income Taxes | -86 | -94 | 945 | — | — | — | — | — | — | |
| Consolidated Net Income | -48 | -394 | 3,828 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | 4 | -346 | 3,876 | — | — | — | — | — | — | |
| Net Income | -48 | -394 | 3,828 | — | — | — | — | — | — | |
| EPS (Recurring) | -0.21 | -1.77 | 17.21 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.21 | -1.77 | 17.21 | — | — | — | — | — | — | |
| EPS (Diluted) | -0.21 | -1.77 | 17.18 | — | — | — | — | — | — | |
| EBITDA | 4,379 | 1,338 | 6,491 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | 17.33 | — | — | — | — | — | — | |
| Price To Sales Ratio | 5.43 | 5.05 | 5.49 | — | — | — | — | — | — | |
| Gross Margin | 32.05 | 31.41 | 32.49 | — | — | — | — | — | — | |
| Operating Margin | -4.70 | -7.29 | 36.91 | — | — | — | — | — | — | |
| Net Margin | -0.38 | -3.27 | 31.63 | — | — | — | — | — | — | |
| Shares Outstanding | 223 | 223 | 223 | — | — | — | — | — | — | |
| Market Capitalization | 68,494 | 60,817 | 66,396 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Schaeffer Melissa N. | Exec Vice President and CFO | May 01 '26 | Sale | 303.76 | 2,714 | 824,405 | 14,212 | May 04 |
| Mantle Ridge LP | director, other: Director by deputization | Feb 12 '26 | Sale | 284.21 | 70,175 | 19,944,437 | 93,499 | Feb 13 |
| Evans Andrew W | Director | Apr 03 '25 | Sale | 283.20 | 5 | 1,416 | 5 | Nov 21 |
| Evans Andrew W | Director | Apr 02 '25 | Buy | 294.96 | 5 | 1,475 | 10 | Nov 21 |
| Brifo Victoria | Exec VP, Chief HR Officer | Aug 05 '25 | Sale | 292.38 | 1,359 | 397,344 | 8,686 | Aug 06 |
| Nelson Walter L. | Sr. VP, Glob Helium & Rare Gas | Mar 05 '25 | Sale | 308.50 | 589 | 181,707 | 719 | Mar 06 |
| Lefevere Kurt | President, Asia | Feb 20 '25 | Sale | 316.17 | 1,500 | 474,255 | 1,462 | Feb 21 |
| Brifo Victoria | Exec VP, Chief HR Officer | Feb 18 '25 | Sale | 315.82 | 2,362 | 745,967 | 10,045 | Feb 19 |
| Bols Ivo | President, Europe & Africa | Feb 18 '25 | Sale | 313.82 | 18,000 | 5,648,760 | 10,088 | Feb 19 |
| Mok Wilbur | President, Equip. Businesses | Feb 18 '25 | Sale | 315.88 | 1,300 | 410,644 | 3,193 | Feb 19 |
| Galovich Brian | Exec VP, CIO | Feb 13 '25 | Sale | 315.79 | 2,089 | 659,685 | 5,278 | Feb 14 |
| Hababou Ahmed | President, Middle East & India | Feb 11 '25 | Sale | 307.97 | 1,608 | 495,216 | 1,906 | Feb 12 |
| Schaeffer Melissa N. | Exec Vice President and CFO | Feb 10 '25 | Sale | 307.32 | 3,233 | 993,566 | 10,680 | Feb 11 |
| Maione Francesco | President, Americas | Feb 10 '25 | Sale | 306.00 | 2,016 | 616,896 | 3,834 | Feb 11 |
| Major Sean D | Executive VP & General Counsel | Feb 07 '25 | Sale | 315.46 | 4,500 | 1,419,570 | 14,273 | Feb 10 |